Market Cap 286.79M
Revenue (ttm) 0.00
Net Income (ttm) -86.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 158,800
Avg Vol 290,432
Day's Range N/A - N/A
Shares Out 50.23M
Stochastic %K 85%
Beta 0.43
Analysts Strong Sell
Price Target $22.00

Latest News on AURA

Aura Biosciences to Participate in Upcoming Investor Conferences

Feb 25, 2025, 7:00 AM EST - 2 months ago

Aura Biosciences to Participate in Upcoming Investor Conferences


3 Small-Cap Stocks Ready to Deliver Significant Growth

Oct 15, 2024, 12:40 PM EDT - 6 months ago

3 Small-Cap Stocks Ready to Deliver Significant Growth

FBRT TZOO


Aura Biosciences: Highly Derisked Late-Stage Eye Cancer Company

Sep 17, 2024, 12:31 PM EDT - 7 months ago

Aura Biosciences: Highly Derisked Late-Stage Eye Cancer Company


Aura Biosciences Touts Promising Data From Eye Cancer Candidate

Sep 12, 2024, 11:40 AM EDT - 7 months ago

Aura Biosciences Touts Promising Data From Eye Cancer Candidate